StockData
Astrana Health, Inc. logo

Astrana Health, Inc. (ASTH) company profile

ASTHNasdaqServices-Management Consulting ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/307% below fair value
$31.80+0.03 (+0.09%)

Close on Nov 13, 2026Market cap $1.77BP/E 29.7Yield –

About Astrana Health

Services-Management Consulting Services, SIC 8742

Astrana Health, Inc. is a healthcare management and care delivery company operating primarily through three core segments: Care Delivery, Care Enablement, and Care Partners. The company provides healthcare patient services, management services, and capitated healthcare arrangements. Through its network relationships, management contracts, and affiliated independent physician associations, it coordinates and delivers medical care. Its primary customers and payors comprise patients and members enrolled in Medicare, Medicaid, and commercial health plans, alongside affiliated physicians and medical groups.

The company conducts its operations within the United States, with documented organizational activities and affiliated healthcare entities in California, Texas, and Connecticut. Astrana Health operates through clinical practices, diagnostic and surgical centers, and laboratory facilities. The company is incorporated under the laws of Delaware and maintains its corporate headquarters and principal executive offices in Alhambra, California.

Summary of the business section of Astrana Health's latest annual report, written by StockData.

Company profile

Company

Legal name
Astrana Health, Inc.
Headquarters
Alhambra, CA
Address
1668 S. Garfield Avenue, 2nd Floor 91801
Phone
(626) 282-0288
Employees
3,000, Dec 31, 2025
Industry
Services-Management Consulting Services
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Ernst & Young LLP, Los Angeles, California

Stock & identifiers

Ticker
ASTH
Former tickers
AMEH until Feb 26, 2024
Exchange
Nasdaq
IPO date
Mar 11, 2009
Shares outstanding
56M, Aug 3, 2026
Public float
$1.10B, Jun 30, 2025
Filer category
Large accelerated filer
Stock splits
1-for-10 reverse, Apr 27, 2015
SEC CIK
1083446
CUSIP
03763A207
ISIN
US03763A2078
FIGI
BBG000H7ZK57
Share class FIGI
BBG001S96MS2
LEI
5493008O4R82Q4STJ936
EIN
87-0042699

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Kenneth T. SimExecutive Chairman, Director7,692,242
John VongSVP - Accounting (PAO)21,132
Brandon SimCEO and President1,880,612
Chandan BashoCOO and CFO155,728
Dinesh M. KumarChief Medical Officer177,655
Thomas S. LamDirector7,729,541
Mitchell W. KitayamaDirector24,337
David SchmidtDirector56,019
John ChiangDirector35,373
Linda DongDirector97,133
Matthew MazdyasniDirector39,288
Dai, WeiliDirector18,188

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$14.93M$5.92M$3.07M$136$148
FY2024
Brandon KSim
$18.24M$16.94M$6.67M$173$129
FY2024
Thomas SLam
$2.84M$2.28M$6.67M$173$129
FY2023
Brandon KSim
$14.31M$13.56M$3.83M$210$126
FY2023
Thomas SLam
$5.22M$4.31M$3.83M$210$126
FY2022$15.30M$997.26K$1.67M$162$124

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsIncentive payOtherTotalvs. prior year
Kenneth Sim, M.D.
Executive Chairman
$950.00K––$24.17K$1.07M-90%
Brandon K. Sim, M.S.
Chief Executive Officer
$850.00K$12.00M$2.06M$21.13K$14.93M-18%
Chandan Basho, M.B.A.
Chief Financial Officer and Chief Operating Officer
$678.08K$2.20M$979.89K$9.09K$3.87M-29%
Dinesh Kumar, M.D.
Chief Medical Officer
$700.00K$2.20M$1.36M$27.47K$4.28M-59%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“As of December 31, 2025, Astrana, its subsidiaries, and consolidated VIEs had approximately 3,000 employees.”

Corporate history

Events identified from SEC filings

DateEventDetails
Mar 2, 2026Late filingNotification of late filing
Jul 2, 2025Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Feb 27, 2025Late filingNotification of late filing
Feb 13, 2024Name changeName changed from Apollo Medical Holdings, Inc. to Astrana Health, Inc.
May 6, 2020Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Apr 28, 2020Auditor changeChange in certifying accountant (8-K Item 4.01)
Sep 6, 2019Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Feb 23, 2018Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 13, 2017Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 7, 2017ListingRegistration of securities on an exchange (Form 8-A)
Aug 11, 2017MergerRegistration of securities for a merger or exchange offer (S-4)
Jun 28, 2016Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Aug 17, 2015Late filingNotification of late filing
Jun 29, 2015Late filingNotification of late filing
May 14, 2015ListingRegistration of securities on an exchange (Form 8-A)
Feb 17, 2015Late filingNotification of late filing
Aug 13, 2014Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
May 15, 2014Auditor changeChange in certifying accountant (8-K Item 4.01)
May 2, 2014Late filingNotification of late filing
Dec 16, 2013Late filingNotification of late filing
Jun 14, 2012Late filingNotification of late filing
Apr 30, 2012Late filingNotification of late filing
Jun 14, 2011Late filingNotification of late filing
May 2, 2011Late filingNotification of late filing
Jun 11, 2010Late filingNotification of late filing
May 3, 2010Late filingNotification of late filing
Apr 30, 2009Late filingNotification of late filing
Dec 15, 2008Late filingNotification of late filing
Jul 15, 2008Name changeName changed from SICLONE INDUSTRIES INC to Apollo Medical Holdings, Inc.
Jun 30, 2008Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)

See a number that looks wrong?